Relapsed or Refractory Chronic Myelomonocytic Leukemia
2 clinical trials · Condition
◉ Watch Relapsed or Refractory Chronic Myelomonocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002) (NCT05038800) | Merck Sharp & Dohme LLC | 2021-09-26 |
Track Relapsed or Refractory Chronic Myelomonocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.